[ad_1]
The corona virus vaccine received 50 million doses of orders from the CEO of Sinovac Biotech of China, Turkey, according to court records, said to have bribed drug regulatory agencies to expedite approval of the vaccine in China.
According to the world news; Covidien-19 vaccine developed by Turkey, trying to provide developing countries to Brazil and Indonesia Sinovac has long been in China’s pharmaceutical industry is experiencing difficulties in discussing vaccines and poor transparency.
Sinovac, whose clinical trials are in the same final stage as Moderna and Pfizer-BioNTechs, is one of two pioneers of the COVID-19 vaccine in China. Nationally, the Sinovac vaccine ranks second, where Sinopharm’s state-owned vaccines are most widely applied under an emergency use program. Another Chinese vaccine developed by CanSino and a military research institute has been approved by the Chinese military for emergency use.
Sinovac’s vaccine, Coronavac, could be rolled out in several emerging markets. Officials from Brazil and Indonesia, the most populous countries in Latin America and Southeast Asia, say Coronavac could be approved in the coming weeks. In Brazil, the governor of São Paulo, João Doria, described it as the safest vaccine the country has ever tried.
Sinovac has yet to release efficacy data for the vaccine, leaving it unclear whether its vaccine could successfully protect recipients, as well as the Moderna and Pfizer vaccines, which were more than 90 percent effective in preliminary analyzes.
Sinovac admitted to the bribery case involving its CEO, saying he cooperated with prosecutors on regulatory files and was not charged, while CEO Yin Weidong said in his testimony that the regulator could not deny money claims.
Sinovac has not been involved in security scandals and there is no evidence that any of the approved vaccines in bribery cases were at fault. But some medical experts say greater scrutiny of Sinovac’s drug claims is necessary given its history of moral flexibility.
“The company’s history of bribery casts a large shadow of doubt on the unpublished, peer-reviewed data claims about the vaccine,” said Arthur Caplan, director of the department of medical ethics at the University of Langone Medical Center. New York. “Even in a plague, a company with a morally dubious track record should be treated very carefully with its claims,” he said.
Although Sinovac’s history of bribery has raised concerns among investors in the Nasdaq-listed company, it has only been on record in recent months regarding such global consequences. Governments are weighing the risks of new vaccines from companies like Sinovac with the certainty that there will be more deaths if the pandemic continues.
A review of public records and trial testimony by The Washington Post shows that Sinovac’s rise to the forefront of the Chinese vaccine industry was aided by Beijing priority projects and commissions for regulatory reviews and officials who helped with sales deals. . Due to China’s censored media, some details of the cases were not previously reported.
In 2016, Yin Weidong, Sinovac’s founder and CEO, admitted to bribing Yin Hongzhang, a regulatory official who oversees vaccine reviews, and his wife for more than $ 83,000. Yin Hongzhang admitted, in return, that Sinovac sped up its vaccination certificates.
Those years were seen as the Sinovac boom, when Beijing authorities chose the biotech startup founded in 2001 to lead the development of vaccines for SARS, bird flu and swine flu.
Yin Hongzhang, who shares the same last name but is not related to Sinovac’s chief executive, was sentenced to 10 years in prison in 2017 for bribing Sinovac and seven other companies. Yin Weidong has not been indicted by Sinovac and continues to oversee the company’s COVID-19 vaccine initiative.
For Sinovac, this case is not an isolated event, between 2008 and 2016, at least 20 government officials and hospital managers in five provinces admitted in court that they had received bribes from Sinovac employees.
Last News
The number of COVID-19 patients in treatment worldwide has exceeded 19 million Health Minister Koca drew attention to the increased risk in 5 provinces The EU and the UK will continue negotiations on Sunday Exports US Arms Hit $ 175 Billion in 2020 Market Summary
